SlideShare una empresa de Scribd logo
1 de 31
W H A T  I S  N E W  I N  M E D I C I N E ?
DR. G. C. DHAR. NOVEMBER 2008
T H I N K  A B O U T  F L U R O Q U I N O L O N E S !
.  FDA “BLACK BOX” WARNING TO FLUROQUINOLONES ,[object Object],[object Object]
FDA “BLACK BOX” WARNING TO FLUROQUINOLONES ,[object Object],[object Object],[object Object],[object Object],[object Object]
FDA “BLACK BOX” WARNING TO FLUROQUINOLONES ,[object Object],[object Object],[object Object],[object Object]
FDA “BLACK BOX” WARNING TO FLUROQUINOLONES REF: Published 15 July 2008, doi:10.1136/bmj.a816
Azithromycin eye drop ,[object Object],[object Object]
Azithromycin eye drop ,[object Object],[object Object]
SLEEP IN  HYPERTENSIVES
Sleep duration and CV Risk in HTN ,[object Object],[object Object],[object Object]
NEW ANTI-HYPERTENSIVE! ALISKIREN RENIN BLOCKER
R  A  A  S
NEW ANTI-HYPERTENSIVE! ,[object Object],[object Object],[object Object],[object Object],[object Object]
hs-CRP ?
A Simple Blood Test  hs-CRP   ,[object Object],[object Object],[object Object]
M I X E D D Y S L I P I D E M I A ? H O W  T O M A N A G E ?
Total Cholesterol: 289mg/dl. HDL-C: 32mg/dl LDL-C: 209mg/dl TG: 386mg/dl.
MIXED DYSLIPIDEMIA ,[object Object],[object Object]
DO YOU KNOW THAT STATINS FIGHT INFECTIONS?
Statins Reduce Death Risks from Pneumonia
Statin and prognosis of pneumonia ,[object Object],[object Object]
Statin in infection ,[object Object],[object Object],d.
Statin in infection ,[object Object],[object Object],[object Object],[object Object],[object Object]
P  H  O  T  O Q  U  I  Z
29 year old man came to you for employment physical examination. ,[object Object],[object Object],[object Object]
 
 
W  H  A  T I  S Y  O  U  R D  I  A  G  N  O  S  I  S  ?
skin findings reveal acanthosis nigricans, a sign of insulin resistance syndrome. Dx: Type 2 DM with dyslipidemia .
T  H  A  N  K  S  !

Más contenido relacionado

La actualidad más candente

Fun In Cardiology Pscc
Fun In Cardiology PsccFun In Cardiology Pscc
Fun In Cardiology Pscchospital
 
Comparison of the efficacy and safety of new oral anticoagulants with warfari...
Comparison of the efficacy and safety of new oral anticoagulants with warfari...Comparison of the efficacy and safety of new oral anticoagulants with warfari...
Comparison of the efficacy and safety of new oral anticoagulants with warfari...Khairunnisa Zamri
 
First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...
First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...
First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...Leonard Davis Institute of Health Economics
 
Negligence in Prescribe Drugs Cases (Amputation legs and hands)
Negligence in Prescribe Drugs Cases (Amputation legs and hands)Negligence in Prescribe Drugs Cases (Amputation legs and hands)
Negligence in Prescribe Drugs Cases (Amputation legs and hands)Nur Ain Atiqa Azeman
 
Pharmacotherapy in HFrEF
Pharmacotherapy in  HFrEFPharmacotherapy in  HFrEF
Pharmacotherapy in HFrEFdrucsamal
 
Role of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. Jaykishan
Role of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. JaykishanRole of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. Jaykishan
Role of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. JaykishanSingh45
 
Ras-cuing the Heart (Cardiology 2011)
Ras-cuing the Heart (Cardiology 2011)Ras-cuing the Heart (Cardiology 2011)
Ras-cuing the Heart (Cardiology 2011)Fraz Ismat
 
Xarelto clinical trial brochure
Xarelto clinical trial brochure Xarelto clinical trial brochure
Xarelto clinical trial brochure noveloac
 
Transition study and Pioneer HF study
Transition study and Pioneer HF studyTransition study and Pioneer HF study
Transition study and Pioneer HF studyEdgardo Kaplinsky
 
Trastornos del potasio1
Trastornos del potasio1 Trastornos del potasio1
Trastornos del potasio1 Luis Barzallo
 
clopidogrel (old is gold)
clopidogrel (old is gold)clopidogrel (old is gold)
clopidogrel (old is gold)Ahmed Taha
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsahvc0858
 

La actualidad más candente (17)

Fun In Cardiology Pscc
Fun In Cardiology PsccFun In Cardiology Pscc
Fun In Cardiology Pscc
 
Comparison of the efficacy and safety of new oral anticoagulants with warfari...
Comparison of the efficacy and safety of new oral anticoagulants with warfari...Comparison of the efficacy and safety of new oral anticoagulants with warfari...
Comparison of the efficacy and safety of new oral anticoagulants with warfari...
 
NOAC( Novel Oral Anticoagulants) uses in the current era
NOAC( Novel Oral Anticoagulants) uses in the current eraNOAC( Novel Oral Anticoagulants) uses in the current era
NOAC( Novel Oral Anticoagulants) uses in the current era
 
First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...
First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...
First Listed Diagnostic Codes Functioned Well to Identify Hosptialization and...
 
Negligence in Prescribe Drugs Cases (Amputation legs and hands)
Negligence in Prescribe Drugs Cases (Amputation legs and hands)Negligence in Prescribe Drugs Cases (Amputation legs and hands)
Negligence in Prescribe Drugs Cases (Amputation legs and hands)
 
Pharmacotherapy in HFrEF
Pharmacotherapy in  HFrEFPharmacotherapy in  HFrEF
Pharmacotherapy in HFrEF
 
Role of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. Jaykishan
Role of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. JaykishanRole of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. Jaykishan
Role of Noac (Newer oral aticoagulants) in covid 19 treatment Dr. Jaykishan
 
International Journal of Case Reports & Short Reviews
International Journal of Case Reports & Short ReviewsInternational Journal of Case Reports & Short Reviews
International Journal of Case Reports & Short Reviews
 
Ras-cuing the Heart (Cardiology 2011)
Ras-cuing the Heart (Cardiology 2011)Ras-cuing the Heart (Cardiology 2011)
Ras-cuing the Heart (Cardiology 2011)
 
International Journal of Cardiovascular Diseases & Diagnosis
International Journal of Cardiovascular Diseases & DiagnosisInternational Journal of Cardiovascular Diseases & Diagnosis
International Journal of Cardiovascular Diseases & Diagnosis
 
Xarelto clinical trial brochure
Xarelto clinical trial brochure Xarelto clinical trial brochure
Xarelto clinical trial brochure
 
Oral apixaban
Oral apixabanOral apixaban
Oral apixaban
 
Ensayos clínicos en IC preservada: resultados del PARAGON-HF
Ensayos clínicos en IC preservada: resultados del PARAGON-HFEnsayos clínicos en IC preservada: resultados del PARAGON-HF
Ensayos clínicos en IC preservada: resultados del PARAGON-HF
 
Transition study and Pioneer HF study
Transition study and Pioneer HF studyTransition study and Pioneer HF study
Transition study and Pioneer HF study
 
Trastornos del potasio1
Trastornos del potasio1 Trastornos del potasio1
Trastornos del potasio1
 
clopidogrel (old is gold)
clopidogrel (old is gold)clopidogrel (old is gold)
clopidogrel (old is gold)
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
 

Destacado

Twitter en facebook verenigingen
Twitter en facebook verenigingenTwitter en facebook verenigingen
Twitter en facebook verenigingennesseam
 
Quel enseignement du fait religieux ?
Quel enseignement du fait religieux ? Quel enseignement du fait religieux ?
Quel enseignement du fait religieux ? icm13
 
Technology
TechnologyTechnology
Technologyperkinse
 
P sipeyre, experience pedagogique
P sipeyre, experience pedagogiqueP sipeyre, experience pedagogique
P sipeyre, experience pedagogiqueicm13
 

Destacado (8)

Twitter en facebook verenigingen
Twitter en facebook verenigingenTwitter en facebook verenigingen
Twitter en facebook verenigingen
 
Quel enseignement du fait religieux ?
Quel enseignement du fait religieux ? Quel enseignement du fait religieux ?
Quel enseignement du fait religieux ?
 
Technology
TechnologyTechnology
Technology
 
TU Delft Open Education for NTNU
TU Delft Open Education for NTNUTU Delft Open Education for NTNU
TU Delft Open Education for NTNU
 
Schreiner group
Schreiner groupSchreiner group
Schreiner group
 
P sipeyre, experience pedagogique
P sipeyre, experience pedagogiqueP sipeyre, experience pedagogique
P sipeyre, experience pedagogique
 
Power En Català  Ana Del Barrio
Power En Català  Ana Del BarrioPower En Català  Ana Del Barrio
Power En Català  Ana Del Barrio
 
Bafp Free 2009
Bafp Free 2009Bafp Free 2009
Bafp Free 2009
 

Similar a Nem Nov 08

Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...
Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...
Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...Dragana Sarenac
 
REVIEW ARTICLE SEPTEMBER 2021 medical.pptx
REVIEW ARTICLE SEPTEMBER 2021 medical.pptxREVIEW ARTICLE SEPTEMBER 2021 medical.pptx
REVIEW ARTICLE SEPTEMBER 2021 medical.pptxArunDeva8
 
Cardiovascular Effects of Phenytoin
Cardiovascular Effects of PhenytoinCardiovascular Effects of Phenytoin
Cardiovascular Effects of PhenytoinAde Wijaya
 
Oxidation and Inflammation
Oxidation and InflammationOxidation and Inflammation
Oxidation and InflammationJohn Bergman
 
Neuro-Interventional Use Of Antiplatelets.pptx
Neuro-Interventional Use Of Antiplatelets.pptxNeuro-Interventional Use Of Antiplatelets.pptx
Neuro-Interventional Use Of Antiplatelets.pptxMohamed M.A. Zaitoun
 
Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...
Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...
Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...CrimsonPublishersAICS
 
Journal club presentation
Journal club presentationJournal club presentation
Journal club presentationshahed1982
 
El ser de seres
El ser de seresEl ser de seres
El ser de seresErickMalo2
 
Acei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendroAcei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendroSuharti Wairagya
 
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4Javeriya_PPCD
 
Twilight trila journal club
Twilight trila journal clubTwilight trila journal club
Twilight trila journal clubPriyanka Thakur
 
Role of antiplatelets in cardiovascular diseases.pptx
Role of antiplatelets in cardiovascular diseases.pptxRole of antiplatelets in cardiovascular diseases.pptx
Role of antiplatelets in cardiovascular diseases.pptxMohamedSabry35679
 
Intensive Antiplatelet Therapy in ACS.pptx
Intensive Antiplatelet Therapy in ACS.pptxIntensive Antiplatelet Therapy in ACS.pptx
Intensive Antiplatelet Therapy in ACS.pptxAlexanderJosethang1
 
Role of DAPT In ACS patients.Cardiologypptx
Role of DAPT In ACS patients.CardiologypptxRole of DAPT In ACS patients.Cardiologypptx
Role of DAPT In ACS patients.CardiologypptxSpandanaRallapalli
 
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...cacao83
 
Antiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptxAntiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptxParikshitMishra15
 

Similar a Nem Nov 08 (20)

CONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTSCONTROVERSIES FOR ASIAN PATIENTS
CONTROVERSIES FOR ASIAN PATIENTS
 
Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...
Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...
Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...
 
REVIEW ARTICLE SEPTEMBER 2021 medical.pptx
REVIEW ARTICLE SEPTEMBER 2021 medical.pptxREVIEW ARTICLE SEPTEMBER 2021 medical.pptx
REVIEW ARTICLE SEPTEMBER 2021 medical.pptx
 
Jose luis ferreiro simposio cangrelor
Jose luis ferreiro   simposio cangrelorJose luis ferreiro   simposio cangrelor
Jose luis ferreiro simposio cangrelor
 
Cardiovascular Effects of Phenytoin
Cardiovascular Effects of PhenytoinCardiovascular Effects of Phenytoin
Cardiovascular Effects of Phenytoin
 
Oxidation and Inflammation
Oxidation and InflammationOxidation and Inflammation
Oxidation and Inflammation
 
Neuro-Interventional Use Of Antiplatelets.pptx
Neuro-Interventional Use Of Antiplatelets.pptxNeuro-Interventional Use Of Antiplatelets.pptx
Neuro-Interventional Use Of Antiplatelets.pptx
 
Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...
Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...
Relapsing Urinary Catheter Bleeding with Triple Antithrombotic Therapy in an ...
 
Heart .pptx
Heart .pptxHeart .pptx
Heart .pptx
 
Journal club presentation
Journal club presentationJournal club presentation
Journal club presentation
 
Lipid and Stroke
Lipid and StrokeLipid and Stroke
Lipid and Stroke
 
El ser de seres
El ser de seresEl ser de seres
El ser de seres
 
Acei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendroAcei foundation of raas blocker in combination therapy by dr hendro
Acei foundation of raas blocker in combination therapy by dr hendro
 
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
Pakistan Pharma Career Door Newsletter ,Issue 4, Volume 4
 
Twilight trila journal club
Twilight trila journal clubTwilight trila journal club
Twilight trila journal club
 
Role of antiplatelets in cardiovascular diseases.pptx
Role of antiplatelets in cardiovascular diseases.pptxRole of antiplatelets in cardiovascular diseases.pptx
Role of antiplatelets in cardiovascular diseases.pptx
 
Intensive Antiplatelet Therapy in ACS.pptx
Intensive Antiplatelet Therapy in ACS.pptxIntensive Antiplatelet Therapy in ACS.pptx
Intensive Antiplatelet Therapy in ACS.pptx
 
Role of DAPT In ACS patients.Cardiologypptx
Role of DAPT In ACS patients.CardiologypptxRole of DAPT In ACS patients.Cardiologypptx
Role of DAPT In ACS patients.Cardiologypptx
 
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
Thuốc điều trị tăng huyết áp trên bệnh thận đái tháo đường - BS Phạm Văn Bù...
 
Antiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptxAntiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptx
 

Más de Gauranga Dhar

Management Of Obesity In Family Practice Cme 30 May08
Management Of Obesity In Family Practice Cme 30 May08Management Of Obesity In Family Practice Cme 30 May08
Management Of Obesity In Family Practice Cme 30 May08Gauranga Dhar
 
Dyslpidemia Cme Com 25 May09
Dyslpidemia Cme  Com 25 May09Dyslpidemia Cme  Com 25 May09
Dyslpidemia Cme Com 25 May09Gauranga Dhar
 

Más de Gauranga Dhar (6)

2014 november-nem
2014 november-nem2014 november-nem
2014 november-nem
 
Nem Dec 09
Nem Dec 09Nem Dec 09
Nem Dec 09
 
Nem Oct 09
Nem Oct 09Nem Oct 09
Nem Oct 09
 
Nem Oct 08
Nem Oct 08Nem Oct 08
Nem Oct 08
 
Management Of Obesity In Family Practice Cme 30 May08
Management Of Obesity In Family Practice Cme 30 May08Management Of Obesity In Family Practice Cme 30 May08
Management Of Obesity In Family Practice Cme 30 May08
 
Dyslpidemia Cme Com 25 May09
Dyslpidemia Cme  Com 25 May09Dyslpidemia Cme  Com 25 May09
Dyslpidemia Cme Com 25 May09
 

Nem Nov 08